OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Endocrinology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Mineralocorticoid receptor antagonists for primary aldosteronism—appropriate or not?	477
Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis	275
EndoCompass project: research roadmap for growth disorders	170
18-year change in serum intact fibroblast growth factor 23 from midlife to late life and risk of mortality: the ARIC Study	128
OC45 - IL-1β/CXCL12 axis drives the crosstalk between PanNET cells and adipocytes	126
OC40 - Aldosterone/cortisol ratio as a new marker for diagnosing mild autonomous cortisol secretion (MACS). Investigating the effects of mild hypercortisolism on the renin-angiotensin-aldosterone syst	118
P12 - Morning spot urine iodine-to-creatinine ratio as a surrogate for 24-hour iodine excretion in adult non-pregnant women	94
Prevalence and determinants of dyslipidemia in 2338 Dutch childhood cancer survivors: a DCCS-LATER 2 study	87
Synchronous bilateral adrenalectomy for ACTH-independent Cushing's syndrome in children: multidisciplinary management	74
Challenges estimating the effects of testosterone on health outcomes in transgender men: immortal time bias and other methodological concerns	73
Extensive expertise in endocrinology: adrenal crisis in assisted reproduction and pregnancy	73
EndoCompass project: the place of endocrinology in European research funding—an analysis of Horizon 2020	67
Serum diiodotyrosine – a biomarker to differentiate destructive thyroiditis from Graves’ disease	63
When selection becomes selection bias	61
Compression of the optic chiasm is associated with reduced photoentrainment of the central biological clock	60
Accurate diagnosis of congenital adrenal hyperplasia due to CYP21A2 variants requires promoter analysis	55
Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study	53
Autophagy markers are decreased in bone of osteoporotic patients: a monocentric comparative study	51
A larger brown fat volume and lower radiodensity are related to a greater cardiometabolic risk, especially in young men	51
Primary adrenal insufficiency in patients with CPOX gene mutations	49
Differential effects of sodium–glucose cotransporter 2 inhibitors on cardiovascular and renal outcomes according to renal function: a dose–response meta-analysis involving 10 randomized clinical trial	47
Two-year clinical outcomes of microwave ablation for benign thyroid nodules: results from a multicenter study	46
Biallelic POC1A variants cause syndromic severe insulin resistance with muscle cramps	45
Ectopic lipid deposition and insulin resistance in patients with GH disorders before and after treatment	44
Metformin treatment is associated with reduced risk of hypoglycaemia, major adverse cardiovascular events, and all-cause mortality in patients with post-pancreatitis diabetes mellitus: a nationwide co	44

Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study	43
Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors	41
Loss of function of FIGNL1, a DNA damage response gene, causes human ovarian dysgenesis	39
Prevalence of adrenal rest tumors and course of gonadal dysfunction in a clinical sample of men with congenital adrenal hyperplasia: a longitudinal analysis over 10 years	39
Defining benchmark outcomes for transsphenoidal surgery of pituitary adenomas: a multicenter analysis	37
Real-world experience with 11C-methionine positron emission tomography in the management of acromegaly	36
European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group	35
Cardiovascular risk in Danish transgender persons: a matched historical cohort study	35
Radiotherapy in aggressive or dopamine agonists resistant prolactinomas; is it still worthwhile?	35
AMH as part of the diagnostic PCOS workup in large epidemiological studies	34
Soluble alpha klotho—impact of biological variables and reference intervals for adults	34